Showing results for "Sangamo Therapeutics"
industries
New Drug Research at Risk as Biotech Cost-Cutting Empties LabsSangamo Therapeutics Inc.’s cost cuts didn’t hurt just the roughly 162 US workers who lost their jobs this month. It’s also a blow to Jerry Walter, who’s lost five family members and suffered kidney, lung, hearing and heart damage from a rare disease.November 22, 2023
technology
Sangamo Surges After Inking Gene Therapy Deal With BiogenBiogen Inc. and small-cap drug developer Sangamo Therapeutics Inc. entered a partnership to develop gene therapies for diseases attacking the brain and central nervous system, including Alzheimer’s disease and Parkinson’s disease.February 27, 2020